Speaker

Mathieu Nonnenmacher

Vice President, Gene Therapy, Voyager Therapeutics

Mathieu Nonnenmacher, Vice President, Gene Therapy at Voyager Therapeutics, is speaking at 8th CNS Drug Delivery Summit (Boston, United States of America, 1–3 Dec 2026) in the session “Translating ALPL-Mediated BBB Transport into the Clinic: Next-Generation Capsid Engineering for CNS Gene Therapy”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

8th CNS Drug Delivery Summit
1–3 Dec 2026Boston, United States of America
- SpeakerTranslating ALPL-Mediated BBB Transport into the Clinic: Next-Generation Capsid Engineering for CNS Gene Therapy

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mathieu Nonnenmacher, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].